Pomegranate & Urolithin A: The Real Connection

Pomegranate is often called the source of urolithin A, and in a sense that is true. But the fruit itself contains no urolithin A at all. What it carries are the raw materials, and whether your body ever turns them into the finished compound depends almost entirely on the bacteria living in your gut.

What pomegranate actually contains

Pomegranate does not deliver urolithin A directly. Instead, the fruit and its juice are rich in a family of large polyphenols called ellagitannins, the most abundant of which are the punicalagins, along with smaller amounts of free ellagic acid. These molecules are responsible for much of the astringency and deep color associated with pomegranate, and they are among the most concentrated ellagitannin sources in the human diet, alongside walnuts, and certain berries such as raspberries and strawberries.

The important detail is that ellagitannins and ellagic acid are poorly absorbed on their own. When you drink pomegranate juice, the vast majority of these compounds pass through the small intestine intact and arrive in the colon largely unchanged. There, and only there, does the real transformation begin. Ellagitannins are first broken down into ellagic acid, and ellagic acid is then progressively converted by resident gut bacteria into a series of metabolites known as urolithins, of which urolithin A is the one that has drawn the most scientific attention. In other words, pomegranate is a precursor delivery system, not a urolithin A supplement.

The conversion truth: your microbiome decides

This is where the pomegranate story becomes far more personal than most marketing suggests. Urolithin A is a gut postbiotic, meaning it is a compound produced by microbial metabolism rather than something the fruit hands you ready-made. Producing it requires specific bacterial species, and not everyone carries them in sufficient numbers.

Researchers have described distinct urolithin metabotypes, essentially patterns that classify people by which urolithins their gut can produce. Some individuals convert ellagic acid efficiently into urolithin A. Others produce mainly other urolithins, and a meaningful proportion produce very little of any. Reviews of this research consistently estimate that only a minority of adults, often cited in the region of roughly a third to 40 percent, are strong urolithin A producers, and that this capacity shifts with age, diet, antibiotic exposure, and the overall composition of the microbiome. Two people can eat the identical bowl of pomegranate arils and end up with dramatically different internal exposure to urolithin A.

This variability is not a minor footnote. It is the single most important reason that eating more pomegranate is an unreliable strategy for anyone who specifically wants the mitochondrial effects that urolithin A has been studied for.

How much pomegranate would you actually need?

It helps to put the numbers in perspective. The human trials on urolithin A have used doses in the clinically studied range of 500 to 1,000 mg per day of the pure compound. Pomegranate juice and arils contain ellagitannins measured in the tens to low hundreds of milligrams per serving, and that figure represents the precursor, not urolithin A itself.

Because only a fraction of ingested ellagitannins are converted, and because that fraction depends entirely on your personal microbiome, there is no reliable serving of juice or arils that maps onto a studied 500 to 1,000 mg dose of urolithin A. Even a strong converter would need to consume an impractical and sugar-heavy volume of juice daily to approach the exposure delivered in the clinical trials, and a poor converter could drink pomegranate every day and generate almost none. This is the honest reason the fruit cannot be treated as a substitute for the compound that has actually been tested. If you want to understand the whole precursor pathway in more depth, our complete urolithin A guide and our overview of foods highest in urolithin A precursors walk through it step by step.

What urolithin A itself has been shown to do

The reason any of this matters is the mechanism. Urolithin A supports a cellular housekeeping process called mitophagy, the targeted recycling of worn-out mitochondria so that healthier ones can take their place. You can read a plain-language explanation in our article on what mitophagy is and how it connects to broader mitochondrial health.

Human evidence (strongest first)

In a first-in-human study, Andreux and colleagues (2019, Nature Metabolism) reported that urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a measurable mitochondrial gene-expression signature in older adults. In a randomized trial in older adults over roughly four months, Liu, D'Amico and colleagues (2022, JAMA Network Open) observed improvements in muscle endurance, measured as the number of muscle contractions before fatigue. A separate randomized trial in middle-aged adults by Singh and colleagues (2022, Cell Reports Medicine), using 500 mg and 1,000 mg arms, reported benefits for muscle strength and aspects of exercise performance. More recent human work published in Nature Aging (2025) found that urolithin A supported the mitochondrial health of immune cells in midlife adults over about 28 days.

Preclinical evidence (animal and cell studies, not human proof)

The foundational work by Ryu and colleagues (2016, Nature Medicine) demonstrated that urolithin A induced mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. This preclinical research is what first motivated the human trials, but findings in worms and rodents should be understood as mechanism-generating, not as evidence of the same outcomes in people.

Taken together, a 2024 systematic review in Ageing Research Reviews described the human evidence as still emerging, drawn from relatively short trials with modest sample sizes. That is an honest and accurate summary, and it applies whether the urolithin A reaches you from a supplement or, in far less predictable amounts, from fruit.

So is pomegranate worthless? No.

None of this means pomegranate is not worth eating. It is a nutrient-dense whole food, a genuine source of the ellagitannin precursors, and a reasonable part of a varied diet. The point is narrower and more precise: pomegranate is not a dependable way to reach the urolithin A exposure that the clinical trials actually studied, because the conversion step is outside your control. Pomegranate is a healthy fruit. It is not a controlled dose. If your interest is specifically in mitophagy support, the fruit and the standardized compound are simply not interchangeable. Nutrition and supplementation are not a treatment for any medical condition, and if you have specific health concerns you should discuss them with your doctor.

If you want the finished compound in a predictable dose rather than leaving it to your microbiome, our roundup of the best urolithin A gummies is a useful next read.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.